| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44029873 | HTLV-1 | ENSG00000162989.5 | protein_coding | KCNJ3 | No | No | 3760 | D2X9V0 D2XBF0 P48549 |
| TVIS44044467 | HTLV-1 | ENSG00000162989.5 | protein_coding | KCNJ3 | No | No | 3760 | D2X9V0 D2XBF0 P48549 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | KCNJ3 |
|---|---|
| DrugBank ID | DB00289 |
| Drug Name | Atomoxetine |
| Target ID | BE0001028 |
| UniProt ID | P48549 |
| Regulation Type | inhibitor |
| PubMed IDs | 20393461 |
| Citations | Kobayashi T, Washiyama K, Ikeda K: Inhibition of G-protein-activated inwardly rectifying K+ channels by the selective norepinephrine reuptake inhibitors atomoxetine and reboxetine. Neuropsychopharmacology. 2010 Jun;35(7):1560-9. doi: 10.1038/npp.2010.27. Epub 2010 Mar 10. |
| Groups | Approved |
| Direct Classification | Phenol ethers |
| SMILES | CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1 |
| Pathways | |
| PharmGKB | PA134688071 |
| ChEMBL | CHEMBL641 |
